These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FDA finalizing policy statement on industry-supported activities. Am J Hosp Pharm; 1993 Mar; 50(3):391. PubMed ID: 8442443 [No Abstract] [Full Text] [Related]
5. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate. Chen P; Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981 [No Abstract] [Full Text] [Related]
6. Truth in advertising: FDA approval and the physician's responsibility. Knapp RM Anesthesiology; 1992 Mar; 76(3):477-8. PubMed ID: 1539866 [No Abstract] [Full Text] [Related]
7. FDA and Pharmanex clash over dietary supplement. Nat Biotechnol; 1997 Jun; 15(6):489. PubMed ID: 9181558 [No Abstract] [Full Text] [Related]
13. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
14. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice. Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275 [TBL] [Abstract][Full Text] [Related]
15. FDA tightens rules on advertising. Josefson D BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658 [No Abstract] [Full Text] [Related]
16. Mission: promoting, protecting the public health. FDA Commissioner Mark B. McClellan. Interview by Ray Formanek Jr. McClellan MB FDA Consum; 2003; 37(2):12-7. PubMed ID: 12715764 [No Abstract] [Full Text] [Related]
17. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products. Lang L Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067 [No Abstract] [Full Text] [Related]
18. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Kesselheim AS; Fischer MA; Avorn J Health Aff (Millwood); 2006; 25(4):1095-102. PubMed ID: 16835191 [TBL] [Abstract][Full Text] [Related]
19. New DTC guidelines please drug companies, anger critics. Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080 [No Abstract] [Full Text] [Related]
20. FDA vs. free speech over drug promotions. Anderson C Nature; 1991 Dec; 354(6353):421. PubMed ID: 1749421 [No Abstract] [Full Text] [Related] [Next] [New Search]